B
Biodesix, Inc. Tech Stack
Diagnostic testing company specializing in lung cancer and disease detection
Biodesix develops and commercializes molecular diagnostic tests for lung disease and oncology, with a heavy sales infrastructure (32 active roles) focused on primary care adoption. The company runs parallel diagnostic-test and development-services lines, yet hiring and project focus cluster almost entirely on sales, market expansion, and adoption barriers — signaling that clinical validation and test development are mature, but commercial traction in primary care remains the operational bottleneck.
Tech Stack 36 technologies
Core StackPower BI Talend Apache NiFi Airbyte Informatica Python Java Salesforce AWS AWS RDS CloudWatch Linux MySQL PostgreSQL Docker SharePoint Teams Word Excel PowerPoint CRM Microsoft Office SQL DAX SQL Server Integration Services LIMS VPC IAM Apache HPLC+1 more
What Biodesix, Inc. Is Building
◆Challenges
- Adoption of diagnostic products in primary care
- Market competition in primary care
- Low adoption of diagnostic tests
- Increasing market presence
- Increasing product adoption in primary care
- Barriers to adoption
- Increasing regional sales
- Process inefficiencies in home phlebotomy
- Slow commercialization of pipeline tests
- Driving market growth
▲Active Projects
- Strategic sales plans for primary care
- Adoption of biodesix products in primary care
- Heor tool development
- Strategic sales plan development
- Strategic sales plans for market growth
- Protocol development and results interpretation
- Publication/poster/abstract writing
- Increase market presence and product adoption
- Mentor and guide associate sales consultants
- Pipeline ldt launch and commercialization
Hiring Activity
Steady45 roles · 20 in 30d
Department
Seniority
Notable leadership hires: Sales Director
Company intelligence
